Cite
Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience.
MLA
Picard, C., et al. “Prospective Multicentric Molecular Study for Poor Prognosis Fusion Transcripts at Diagnosis in Adult B-Lineage ALL Patients: The LALA 94 Experience.” Leukemia (08876924), vol. 20, no. 12, Dec. 2006, pp. 2178–81. EBSCOhost, https://doi.org/10.1038/sj.leu.2404408.
APA
Picard, C., Hayette, S., Bilhou-Nabera, C., Cayuela, J. M., Delabesse, E., Frenoy, N., Preudhomme, C., Dupont, M., Bastard, C., Bories, D., Vaerman, J. L., Davi, F., Dastugue, N., Raynaud, S., Lafage, M., Deschaseaux, F., Fest, T., Gaub, M. P., Lhéritier, V., & Thomas, X. (2006). Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience. Leukemia (08876924), 20(12), 2178–2181. https://doi.org/10.1038/sj.leu.2404408
Chicago
Picard, C., S. Hayette, C. Bilhou-Nabera, J. M. Cayuela, E. Delabesse, N. Frenoy, C. Preudhomme, et al. 2006. “Prospective Multicentric Molecular Study for Poor Prognosis Fusion Transcripts at Diagnosis in Adult B-Lineage ALL Patients: The LALA 94 Experience.” Leukemia (08876924) 20 (12): 2178–81. doi:10.1038/sj.leu.2404408.